Search Results 101-110 of 9832 for Clostridioides difficile infection

  1. Microbiota Restoration Therapy For Recurrent Clostridium Difficile Infection (PUNCHCD3) - Mayo Clinic

    Microbiota Restoration Therapy For Recurrent Clostridium Difficile Infection (PUNCHCD3) · More about research at Mayo Clinic · Mayo Clinic Footer.

  2. A Study To Evaluate The Safety And Tolerability Of Rebiotix RBX2660 (Microbiota Suspension) In Subjects With Recurrent Clostridium Difficile Infection - Mayo Clinic

    A Study To Evaluate The Safety And Tolerability Of Rebiotix RBX2660 (Microbiota Suspension) In Subjects With Recurrent Clostridium Difficile Infection.

  3. A Study To Evaluate The Effectiveness, Safety, And Tolerability Of A Clostridium Difficile Vaccine In Adults 50 Years Of Age And Older - Mayo Clinic

    About this study. The Clover trial is evaluating an investigational vaccine that may help to prevent Clostridium difficile infection.

  4. Identifying Biomarkers for Recurrent CDI and Post-CDI IBS - Mayo Clinic

    difficile infection irritable bowel syndrome. We will study patient characteristics and study stool samples to investigate if bile acid composition, microbiome ...

  5. A Study of Fecal Microbiota Transplantation for Recurrent Clostridium Difficile Infection on Vancomycin Resistant Enterococci Status of Patients - Mayo Clinic

    The purpose of this study is to evaluate if Vancomycin Resistant Enterococci (VRE) can be eradicated in patients with Clostridium Difficile infection (CDI) ...

  6. C. Diff Infection Risk Rises with Antihistamine Use to Treat Stomach Acid - Mayo Clinic News Network

    ... infection from Clostridium difficile (C. diff), a common cause of diarrhea, particularly in health care settings. However, the researchers found no ...

  7. A Study To Evaluate The Safety, Effectiveness, And Tolerability Of Oral Full-Spectrum Microbiota™ (CP101) In Subjects With Recurrent C. Diff - Mayo Clinic

    ... difficile infection. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...

  8. Open-Label Extension Of CP101 Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) In Subjects With Recurrence Of Clostridium Difficile Infection - Mayo Clinic

    Open-Label Extension Of CP101 Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) In Subjects With Recurrence Of Clostridium Difficile Infection. Print ...

  9. A Trial Of CP101 For The Prevention Of Recurrent CDI (PRISM4) - Mayo Clinic

    ... Clostridioides difficile Infection (CDI) in adult patients. Participation eligibility. Participant eligibility includes age, gender, type and stage of ...

  10. Vancomycin (oral route) - Mayo Clinic

    Vancomycin, when taken by mouth, is used to treat Clostridioides difficile-associated diarrhea (also called C diff). ... Your infection may not clear up if you ...